Brazil to be self-reliant in efavirenz production
This article was originally published in Scrip
Executive Summary
Brazil may soon be self-reliant in the production of efavirenz, says the country's ministry of health. The news comes after the state-owned pharmaceutical lab, Farmanguinhos, announced positive bioavailability test results for its generic version ofMerck Sharp & Dohme's Stocrin (efavirenz).
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.